SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes

NCT00043784 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

8000

Enrollment

INDUSTRY

Sponsor class

Conditions

Unstable Angina
Myocardial Infarction
Myocardial Ischemia

Interventions

DRUG: enoxaparin

Sponsor

Sanofi